Keywords: Lundbeck, Third-quarter 2011 financial results, CNS drugs

Strong 3rd-quarter 2011 sales growth at Lundbeck, but write-off hits profit

Article | 09 November 2011

Print This

Danish CNS drug specialist Lundbeck (LUND: DC) has reported a strong set of financial results for the third quarter of 2011, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in